Selling, General and Administrative Expense - Schedule of Selling, General and Administrative Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Non-cash expenses: | ||
| Bad debt recoveries | $ (381) | $ (99) |
| Stock based compensation | 647 | 241 |
| Total SG&A expense | 8,383 | 8,668 |
| Selling, General and Administrative Expenses | ||
| Cash expenses: | ||
| Compensation and benefits | 4,277 | 2,983 |
| Professional services | 1,929 | 3,637 |
| Other | 1,911 | 1,906 |
| Total cash SG&A expense | 8,117 | 8,526 |
| Non-cash expenses: | ||
| Bad debt recoveries | (381) | (99) |
| Stock based compensation | 647 | 241 |
| Total non-cash SG&A expense | 266 | 142 |
| Total SG&A expense | $ 8,383 | $ 8,668 |
| X | ||||||||||
- Definition Selling General And Administrative Expense, Cash Portion [Abstract] No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Cash Portion No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Including Related and Third Parties No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Non Cash Portion No definition available.
|
| X | ||||||||||
- Definition Selling, General and Administrative Expense, Non Cash Portion [Abstract] No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|